President Donald Trump accepted his party’s nomination in a speech filled with familiar falsehoods.
Health and Human Services Secretary Alex Azar has described a new policy as “unleashing our Medicare Advantage plans to negotiate discounting on $12 billion of drugs.” Some patient advocacy groups have described the policy as one that “could erect barriers to care for cancer” and put “insurers in control of treatment decisions.” We’ll explain what the new policy entails.
Gauging by the attack ads flowing from the Democratic Congressional Campaign Committee, the party’s House contenders are running against Exxon, Pfizer and Bush. The ads tie Republican House candidates to unpopular industries and an unpopular President. Some of these ads are exaggerations.